Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Noviello

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Diagnostics (Basel, Switzerland)|April 17, 2019
The Basics and the Advancements in Diagnosis of Bacterial Lower Respiratory Tract InfectionsStephanie Noviello, David B Huang
Clinical Case Reports|July 8, 2016
Case report: successful retreatment of hepatitis C genotype 1b infection with sofosbuvir + simeprevir in a patient with cirrhosis who had prior virologic relapse after treatment with daclatasvir and asunaprevirRifaat Safadi, Stephanie Noviello, Navdeep Boparai, et al.
Expert Review of Anti-Infective Therapy|October 16, 2018
Iclaprim: a differentiated option for the treatment of skin and skin structure infectionsStephanie Noviello, David B Huang, G Ralph Corey
Journal of Global Antimicrobial Resistance|January 8, 2019
In vitro activity of dihydrofolate reductase inhibitors and other antibiotics against Gram-positive pathogens collected globally between 2004 and 2016Stephanie Noviello, Stephen Hawser, Helio Sader, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2019
<i>In Vitro</i> Activity of Iclaprim against Isolates in Two Phase 3 Clinical Trials (REVIVE-1 and -2) for Acute Bacterial Skin and Skin Structure InfectionsStephanie Noviello, Sophie Magnet, Stephen Hawser, et al.
Rheumatology and Therapy|January 19, 2022
Similar Clinical Outcomes in Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease Treated with Canakinumab: Bayesian and Population Model-Based AnalysesCornelia Dunger-Baldauf, Priscila Nakasato, Stephanie Noviello, et al.
Clinical Therapeutics|April 30, 2019
A Pooled Analysis of the Safety and Efficacy of Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Patients With Intravenous Drug Use: Phase 3 REVIVE StudiesDavid B Huang, Stephanie Noviello, Barbara Balser, et al.
Journal of Medical Microbiology|May 4, 2019
The incidence and patient outcomes of ABSSSI by iclaprim MIC values in the phase 3 REVIVE trials for treatment of acute bacterial skin and skin structure infectionsDavid B Huang, Cedric Charrier, Chloé Le Bras, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2016
12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral RegimensAnne F Luetkemeyer, Cheryl McDonald, Moti Ramgopal, et al.
Emerging Infectious Diseases|October 27, 2004
Laboratory-acquired brucellosisStephanie Noviello, Richard Gallo, Molly Kelly, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Diagnostics (Basel, Switzerland)|April 17, 2019
The Basics and the Advancements in Diagnosis of Bacterial Lower Respiratory Tract InfectionsStephanie Noviello, David B Huang
Clinical Case Reports|July 8, 2016
Case report: successful retreatment of hepatitis C genotype 1b infection with sofosbuvir + simeprevir in a patient with cirrhosis who had prior virologic relapse after treatment with daclatasvir and asunaprevirRifaat Safadi, Stephanie Noviello, Navdeep Boparai, et al.
Expert Review of Anti-Infective Therapy|October 16, 2018
Iclaprim: a differentiated option for the treatment of skin and skin structure infectionsStephanie Noviello, David B Huang, G Ralph Corey
Journal of Global Antimicrobial Resistance|January 8, 2019
In vitro activity of dihydrofolate reductase inhibitors and other antibiotics against Gram-positive pathogens collected globally between 2004 and 2016Stephanie Noviello, Stephen Hawser, Helio Sader, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2019
<i>In Vitro</i> Activity of Iclaprim against Isolates in Two Phase 3 Clinical Trials (REVIVE-1 and -2) for Acute Bacterial Skin and Skin Structure InfectionsStephanie Noviello, Sophie Magnet, Stephen Hawser, et al.
Rheumatology and Therapy|January 19, 2022
Similar Clinical Outcomes in Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease Treated with Canakinumab: Bayesian and Population Model-Based AnalysesCornelia Dunger-Baldauf, Priscila Nakasato, Stephanie Noviello, et al.
Clinical Therapeutics|April 30, 2019
A Pooled Analysis of the Safety and Efficacy of Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Patients With Intravenous Drug Use: Phase 3 REVIVE StudiesDavid B Huang, Stephanie Noviello, Barbara Balser, et al.
Journal of Medical Microbiology|May 4, 2019
The incidence and patient outcomes of ABSSSI by iclaprim MIC values in the phase 3 REVIVE trials for treatment of acute bacterial skin and skin structure infectionsDavid B Huang, Cedric Charrier, Chloé Le Bras, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2016
12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral RegimensAnne F Luetkemeyer, Cheryl McDonald, Moti Ramgopal, et al.
Emerging Infectious Diseases|October 27, 2004
Laboratory-acquired brucellosisStephanie Noviello, Richard Gallo, Molly Kelly, et al.
Pageof 6